| 000 | 01806 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250517034530.0 | ||
| 264 | 0 | _c20160610 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1432-0428 | ||
| 024 | 7 |
_a10.1007/s00125-015-3659-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBonnefond, Amélie | |
| 245 | 0 | 0 |
_aThe loss-of-function PCSK9 p.R46L genetic variant does not alter glucose homeostasis. _h[electronic resource] |
| 260 |
_bDiabetologia _cSep 2015 |
||
| 300 |
_a2051-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHomeostasis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProprotein Convertase 9 |
| 650 | 0 | 4 |
_aProprotein Convertases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSerine Endopeptidases _xblood |
| 650 | 0 | 4 | _aSex Factors |
| 700 | 1 | _aYengo, Loïc | |
| 700 | 1 | _aLe May, Cédric | |
| 700 | 1 | _aFumeron, Fréderic | |
| 700 | 1 | _aMarre, Michel | |
| 700 | 1 | _aBalkau, Beverley | |
| 700 | 1 | _aCharpentier, Guillaume | |
| 700 | 1 | _aFranc, Sylvia | |
| 700 | 1 | _aFroguel, Philippe | |
| 700 | 1 | _aCariou, Bertrand | |
| 773 | 0 |
_tDiabetologia _gvol. 58 _gno. 9 _gp. 2051-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00125-015-3659-8 _zAvailable from publisher's website |
| 999 |
_c24957696 _d24957696 |
||